Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local injection of adipose-derived mesenchymal stem cells for hand skin lesions in systemic sclerosis
CTR20233223Phase 2Active
- Sponsor
- Beijing Aige Stem Cell Technology
- Start
- Nov 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human adipose-derived mesenchymal stem cells for injection in systemic sclerosis (SSc), sponsored by Beijing Aige Stem Cell Technology. Started Nov 2023; status: active.
02
Drugs
human adipose-derived mesenchymal stem cells for injection
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on CTR20233223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233223.